

Major M&A deals this week include: Eli Lilly buys Profluent for $2.2 billion, Lazard buys Campbell Lutyens, FreshRealm bankruptcy.
You can purchase shares of Organon (NYSE:OGN) through any online brokerage.
Other companies in Organon’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Organon has a consensus price target of $14.43.
The stock price for Organon (NYSE: OGN) is $13.84 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Organon.
Organon does not have any upcoming earnings scheduled.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is...